Turkey Services, news and resources from Turkey Tweet Jump to NewsLibrary resources News Hepatitis delta Prolonged pegylated interferon plus tenofovir does not prevent hepatitis delta relapse Liz Highleyman / 23 April 2014 Treating hepatitis B patients with hepatitis delta virus (HDV) co-infection using pegylated interferon plus tenofovir (Viread) for 96 weeks may reduce HDV viral load, but side-effects are frequent and it did not significantly improve ... Antiviral therapy Entecavir and tenofovir both work well against hepatitis B in clinical practice Liz Highleyman / 25 October 2013 Entecavir (Baraclude) and tenofovir (Viread) both demonstrated potent activity against hepatitis B virus (HBV) in a Turkish study presented at the IDWeek 2013 conference held recently in San Francisco. Entecavir appeared to have an ... Treatment issues Turkey’s hepatitis C virus drug market will more than triple by 2017 Decision Resources press release / 07 June 2013 More news Library resources A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel [2012] TypeWeb page Published2013 AuthorLiver International View more resources Do you work for a hepatitis organisation?Add your organisation to the listings >